Reveal LINQ Insertable Cardiac Monitor vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Reveal LINQ Insertable Cardiac Monitor

by Medtronic

Rhythm360

by RhythmScience

AI Verdict

Tool A is an implantable cardiac monitor that uses proprietary AI to improve the accuracy of its own ECG data and reduce false alerts. Tool B is a vendor-neutral, cloud-based platform that aggregates and analyzes cardiac monitoring data from various devices, including those from Medtronic, to provide comprehensive insights, reduce alert fatigue, and streamline clinic workflows. While both leverage AI for cardiac monitoring and alert management, Tool A is a data-generating device, whereas Tool B is a data-integrating and management platform that can potentially enhance the utility of data from devices like Tool A.

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous, and highly accurate ECG monitoring for patients with infrequent or asymptomatic arrhythmias, such as unexplained syncope or suspected atrial fibrillation. Its implantable nature ensures consistent data capture over several years, and its AccuRhythm AI minimizes false alerts, enhancing diagnostic yield for elusive cardiac events.

View Reveal LINQ Insertable Cardiac Monitor →

Choose Rhythm360 if…

Choose Rhythm360 if your cardiology practice or health system needs a comprehensive, vendor-neutral platform to aggregate and manage cardiac monitoring data from a variety of devices. This solution is ideal for streamlining workflows, reducing alert fatigue through AI-driven triage, and automating billing processes, especially when managing a diverse patient population across multiple cardiac conditions like hypertension and heart failure.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Reveal LINQ Insertable Cardiac Monitor	Rhythm360
Pricing	Contact vendor	Flexible pricing model that scales with clinic size and platform usage.
Deployment	Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.	Cloud-based SaaS platform
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Yes AI-estimated	Unknown
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Tool B (Rhythm360) offers a comprehensive, vendor-neutral platform that aggregates data from various cardiac devices, providing a unified clinician experience. Its AI-driven alert triage and bi-directional EHR integration streamline workflows, making it highly usable for clinicians managing diverse patient populations and device types. Tool A (Reveal LINQ ICM) focuses on the usability of its specific device and associated patient app, which is more limited in scope.

Clinical Value

Rhythm360

While Tool A (Reveal LINQ ICM) provides accurate, long-term monitoring with AI for reduced false alerts in specific arrhythmias, Tool B (Rhythm360) offers broader clinical value. It unifies data from multiple devices, provides actionable insights for hypertension, heart failure, and rhythm management, and includes predictive algorithms for heart failure, significantly reducing alert fatigue and improving overall patient management.

Pricing & Value

Tie

Tool A's (Reveal LINQ ICM) pricing is not publicly disclosed, which is typical for medical devices, making a direct cost comparison impossible. Tool B (Rhythm360) offers a flexible, scalable SaaS model but is noted as having 'premium pricing.' Without specific financial details or a clear return on investment analysis for both, it's not possible to definitively determine which offers superior value.

Enterprise Readiness

Rhythm360

Tool B (Rhythm360) demonstrates superior enterprise readiness through its extensive bi-directional EHR integration with major systems like Epic and Cerner, automated CPT code documentation and billing, and vendor-neutral data aggregation from all major OEMs. These features are crucial for seamless integration into complex healthcare IT infrastructures and optimizing operational efficiency. Tool A (Reveal LINQ ICM), while FDA cleared and HIPAA compliant, is a device-specific solution with its own cloud platform.

Innovation

Rhythm360

Tool B (Rhythm360) exhibits broader innovation by applying AI for vendor-neutral data aggregation, AI-driven alert triage (reducing response times by 80%), AI Data Normalization (including computer vision for PDF parsing), and predictive algorithms for heart failure management. Tool A (Reveal LINQ ICM)'s innovation is primarily focused on its AccuRhythmu2122 AI algorithms for reducing false alerts within its specific implantable device.

Support & Docs

Rhythm360

Tool B (Rhythm360) explicitly offers optional 24/7/365 oversight by certified cardiac technicians (CCTs) and provides a knowledge base with common questions and support documentation. While Medtronic (Tool A) provides extensive product manuals and technical support for its devices, the explicit mention of a continuous, high-level oversight service for Tool B gives it a slight edge in terms of clearly defined and advanced support offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Reveal LINQ Insertable Cardiac Monitor	Rhythm360
Primary Function	Long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.	Unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
AI Capabilities	AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause).	AI-driven alert triage (80% faster response times, reduces alert fatigue), AI Data Normalization (API, HL7, XML, PDF parsing via computer vision), predictive algorithms for Heart Failure Management.
Data Source/Aggregation	Continuous, long-term subcutaneous ECG monitoring from the implantable device.	Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik).
EHR Integration	Not specified	Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity).
Specialties Supported	Cardiology, Pediatrics	Cardiology
Key Patient/Clinician Interaction Features	MyCareLink Heartu2122 mobile app for patient data transmission; MyCareLink Relayu2122 home communicator for data transmission; Remote programming capabilities.	HIPAA-compliant mobile application for clinicians; Optional 24/7/365 oversight by certified cardiac technicians (CCTs); Automated CPT code documentation and billing.

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ Insertable Cardiac Monitor and Rhythm360.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with our existing EHR system and streamline the clinical workflow for managing cardiac patients?

Reveal LINQ ICM transmits data to Medtronic's CareLinku2122 network, requiring clinicians to access data through that platform. Rhythm360 offers bi-directional integration with major EHRs like Epic and Cerner, aiming to unify data from various devices directly within existing patient records and automate documentation, thereby streamlining workflows.

How do the AI capabilities of each tool specifically enhance diagnostic accuracy and reduce the burden of alert fatigue for clinicians?

Reveal LINQ ICM utilizes AccuRhythmu2122 AI algorithms to significantly reduce false alerts for atrial fibrillation (AF) and Pause, enhancing diagnostic yield for these specific arrhythmias. Rhythm360 employs AI-driven alert triage across multiple device types, which aims to reduce alert fatigue by 70-80% and achieve faster response times for critical events, while maintaining high accuracy for arrhythmia detection.

What is the clinical scope of each tool, particularly regarding the types of cardiac conditions and monitoring devices they support?

Reveal LINQ ICM is an implantable device primarily focused on long-term subcutaneous ECG monitoring for conditions such as atrial fibrillation, syncope, and cryptogenic stroke, and is also indicated for pediatric patients. Rhythm360 is a vendor-neutral platform that aggregates and analyzes data from all major OEM cardiac monitoring devices, providing actionable insights for hypertension, heart failure, and rhythm management.

What is the expected time-to-value and the learning curve for our clinical team when adopting either of these solutions?

For Reveal LINQ ICM, the time-to-value is tied to the diagnostic yield from the implanted device over its 4.5-year battery life, with a learning curve for interpreting data within the Medtronic CareLinku2122 network. Rhythm360, as a cloud-based SaaS platform with bi-directional EHR integration, aims for rapid implementation, typically within days to weeks, and a shortened learning curve due to its intuitive interface and streamlined workflows.

How easily can these solutions be implemented and scaled across multiple clinical sites or a larger healthcare system?

Implementing Reveal LINQ ICM involves individual device implantation and subsequent patient data transmission to the Medtronic CareLinku2122 network. Rhythm360, as a cloud-based SaaS platform with vendor-neutral data aggregation and bi-directional EHR integration, is designed for scalability and can be readily deployed across multiple sites, supporting tailored workflows for each location.